Regulatory News:

BIOCORP (FR0012788065 – ALCOR / Eligible PEA‐PME) (Paris:ALCOR), a French company specialized in the design, development, and manufacturing of innovative medical devices, presents its agenda of investor meetings and professional conventions in the next few weeks.

  • March 23 & 24, 2022 - French-speaking Diabetes Society (SFD) Congress in Nice (France): Mallya presentation on our partners’ booth Sanofi and Roche Diabetes Care France.
  • April 5, 2022 – Investor Access in Paris (France) : Management will present the 2021 annual financial results and the 2022 outlook to investors.
  • April 27 to 30, 2022 – 15th ATTD (Advanced Technologies & Treatments for Diabetes) conference in Barcelona (Spain): BIOCORP will talk about its latest technological advances concerning Mallya.
  • May 16 & 17, 2022 – PDA Medical Devices and Connected Health Conference in Dublin (Ireland): presentation by Arnaud Guillet (Vice-President Business Development of BIOCORP): “Connected drug delivery devices - Roadmap from commercial pilots to mass adoption, use cases in different regions of the world “.
  • May 18 & 19, 2022 - Biocorp booth at Pharmapack Europe in Paris (France), the European hub of drug delivery devices industry.

ABOUT BIOCORP

Recognized for its expertise in the development and manufacture of medical devices and delivery systems, BIOCORP has today acquired a leading position in the connected medical device market thanks to Mallya. This smart sensor for insulin injection pens allows reliable monitoring of injected doses and thus offers better compliance in the treatment of patients with diabetes. Available for sale from 2020, Mallya spearheads BIOCORP's product portfolio of innovative connected solutions. The company has 70 employees. BIOCORP is listed on Euronext since July 2015 (FR0012788065 – ALCOR).

For more information, please visit www.biocorpsys.com.

BIOCORP Jacques Gardette Chairman of the Board investisseurs@biocorp.fr

Éric Dessertenne Chief Executive Officer

Sylvaine Dessard Marketing & Communication Director rp@biocorp.fr + 33 (0)6 88 69 72 85

CONTACTS ULYSSE COMMUNICATION Bruno ARABIAN barabian@ulysse-communication.com +33 (0)6 87 88 46 26

Nicolas DANIELS ndaniels@ulysse-communication.com +33 (0)6 63 66 59 22

Biocorp (EU:ALCOR)
Historical Stock Chart
Von Mär 2024 bis Apr 2024 Click Here for more Biocorp Charts.
Biocorp (EU:ALCOR)
Historical Stock Chart
Von Apr 2023 bis Apr 2024 Click Here for more Biocorp Charts.